Topics

FDA revoked orphan designation and exclusivity for Sublocade, which was approved in 2017 and seen as a potential game-changer for fightng the #opioid crisis. https://buff.ly/2WVhXTu 

17:00 EST 8 Nov 2019 | STAT

FDA revoked orphan designation and exclusivity for Sublocade, which was approved in 2017 and seen as a potential game-changer for fightng the crisis. https://buff.ly/2WVhXTu 

Original Article: FDA revoked orphan designation and exclusivity for Sublocade, which was approved in 2017 and seen as a potential game-changer for fightng the #opioid crisis. https://buff.ly/2WVhXTu 

NEXT ARTICLE

More From BioPortfolio on "FDA revoked orphan designation and exclusivity for Sublocade, which was approved in 2017 and seen as a potential game-changer for fightng the #opioid crisis. https://buff.ly/2WVhXTu "

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...